What is KLOW BLEND?
KLOW Blend is classified as a research-grade peptide blend — a co-lyophilized preparation in which more than one discrete peptide species is presented together in a single container. Unlike a single-entity peptide, a blend is defined by the identity and relative proportion of its constituent molecules rather than by one molecular formula, and each component retains its own primary amino-acid sequence, molecular weight, and physicochemical behavior within the mixed powder.
Structurally, the "KLOW" designation is used in the research-supply space for a combination of short-chain peptides that are otherwise studied individually. Each constituent is a peptide built from amino-acid residues linked by peptide (amide) bonds; components of this class range from very short tri- and tetrapeptides through longer cationic peptide chains, and one commonly associated constituent is a copper-complexed tripeptide in which a metal ion is coordinated to the peptide backbone. Because the specific per-component molecular data (sequences, formulas, and masses) are not enumerated in the verified data set for this listing, they are intentionally not restated here; the Certificate of Analysis accompanying each lot is the authoritative record of composition and identity.
As a research area, blends of this type are examined in in-vitro and preclinical laboratory models within peptide chemistry and cell-biology programs — for example, studies of peptide stability, solubility, and formulation behavior, and investigations in extracellular-matrix and cell-signaling research with which the individual peptides are associated in the published literature. All such use is exploratory and non-clinical. KLOW Blend is offered for laboratory research use only (RUO) and is not a drug, supplement, or article intended for diagnosis, treatment, or administration to humans or animals.
Reconstitution & handling
KLOW Blend is supplied as a lyophilized (freeze-dried) solid and must be reconstituted before use in solution-phase research. Bacteriostatic water (water for injection containing 0.9% benzyl alcohol) or sterile water is the conventional solvent for handling peptide powders in the laboratory; the diluent is directed slowly down the inner wall of the vial rather than injected forcefully onto the powder cake, and the vial is then left to stand and swirled gently until fully dissolved. Vortexing, shaking, or forcing the powder into solution should be avoided, as mechanical shear and foaming can promote aggregation of peptide chains. Because a blend contains multiple peptides with differing solubility profiles, some constituents may dissolve more readily than others; the solution should be inspected for complete dissolution and clarity, and a copper-complexed component, where present, may impart a characteristic tint to the reconstituted liquid that reflects the metal-peptide coordination rather than a defect. Reconstituted material is chemically less stable than the dry powder and should be prepared only in the quantity a given experiment requires.
Storage & stability
In its lyophilized form, KLOW Blend is most stable and should be stored sealed, protected from light, moisture, and heat; short-term holding is generally at refrigerated temperature (2–8 °C), while long-term storage of the dry powder is best at −20 °C or colder to preserve the integrity of each peptide component. Once reconstituted, the material should be kept refrigerated at 2–8 °C, shielded from light, and used within a short working window; for extended retention of solution, single-use aliquots stored frozen minimize degradation from repeated warming. Repeated freeze–thaw cycles are a primary cause of peptide breakdown and aggregation and should be avoided across both the dry and dissolved states.
How it's tested
Identity and purity of KLOW Blend are established by analytical laboratory methods and documented on a lot-specific Certificate of Analysis (COA). High-performance liquid chromatography (HPLC), typically reverse-phase, is used to resolve the constituent peptides, quantify purity, and confirm the reported specification of ≥99%; because the material is a multi-component blend, chromatography also serves to verify that each expected peptide peak is present and that impurity or degradant peaks fall within specification. Mass spectrometry (commonly ESI- or MALDI-MS) is applied to confirm the molecular mass of the individual components, corroborating identity against their known structures. Together the HPLC and MS results reported on the COA constitute the analytical record of composition, purity, and identity for a given production lot, and the COA is available to support laboratory quality-control and documentation requirements.